Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:48 PM
Ignite Modification Date:
2025-12-24 @ 11:48 PM
NCT ID:
NCT01427751
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of branch retinal vein occlusion in at least one eye
* Visual acuity between 20/400 to 20/40
Exclusion Criteria:
* Active eye infection
* Ocular hypertension which is not controlled on monotherapy (one medication)
* Anticipated need for eye surgery during the study
* Cataract surgery in either eye within 3 months
* Eye surgery including laser of any type within 6 months
* Anti-VEGF treatment in either eye (eg, Lucentis®) within 3 months or systemic anti-VEGF treatment (eg, Avastin) within 6 months
* Use of ocular steroids within 3 months
* Use of steroids (except for inhaled or intranasal) within 1 month or anticipated use during the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01427751
Study Brief:
Protocol Section:
NCT01427751